KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Return on Capital Employed (2016 - 2026)

Merck has reported Return on Capital Employed over the past 18 years, most recently at 5.22% for Q1 2026.

  • Quarterly Return on Capital Employed fell 1083.0% to 5.22% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 5.22% through Mar 2026, down 1083.0% year-over-year, with the annual reading at 4.75% for FY2025, 93.0% down from the prior year.
  • Return on Capital Employed was 5.22% for Q1 2026 at Merck, down from 4.47% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 7.54% in Q3 2025 and troughed at 17.58% in Q4 2023.
  • The 5-year median for Return on Capital Employed is 0.67% (2022), against an average of 2.09%.
  • Year-over-year, Return on Capital Employed tumbled -1642bps in 2023 and then soared 2291bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 1.15% in 2022, then plummeted by -1425bps to 17.58% in 2023, then skyrocketed by 130bps to 5.34% in 2024, then decreased by -16bps to 4.47% in 2025, then crashed by -217bps to 5.22% in 2026.
  • Per Business Quant, the three most recent readings for MRK's Return on Capital Employed are 5.22% (Q1 2026), 4.47% (Q4 2025), and 7.54% (Q3 2025).